Last reviewed · How we verify
Hutchinson-Gilford syndrome
Approved treatments
- Zokinvy · Sentynl Theraps Inc
Lonafarnib prevents farnesylation of progerin and similar proteins by inhibiting farnesyltransferase.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hutchinson-Gilford syndrome patent landscape — cliff calendar, originator estates, attackable patents
- Hutchinson-Gilford syndrome treatment landscape brief
- Hutchinson-Gilford syndrome treatment updates RSS
Frequently asked questions about Hutchinson-Gilford syndrome
What drugs treat Hutchinson-Gilford syndrome?
Tracked treatments include Zokinvy.
What is the treatment for Hutchinson-Gilford syndrome?
Standard treatment for Hutchinson-Gilford syndrome includes Zokinvy. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hutchinson-Gilford syndrome patent cliff · Hutchinson-Gilford syndrome CI report
- Treatment: Zokinvy · Sentynl Theraps Inc
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing